These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 10712086)
1. [Care for life. Central is the patient]. Hilpert U Internist (Berl); 2000 Jan; 41(1):A37. PubMed ID: 10712086 [No Abstract] [Full Text] [Related]
2. Improving outcome in acute coronary syndromes - as good as it gets? Purcell H; Fox KM Eur Heart J; 1999 Nov; 20(21):1533-7. PubMed ID: 10529321 [No Abstract] [Full Text] [Related]
3. [Long-term administration of Dalteparin in unstable coronary syndrome. FRISC II study opens novel therapeutic perspectives. Fragmin and Fast Revascularization during Instability in Coronary Artery Disease]. Arnheim K Internist (Berl); 2000 Jan; 41(1):A35-6. PubMed ID: 10712085 [No Abstract] [Full Text] [Related]
4. [1999 Robert Koch Drug Award for enoxaparin. Safely preventing thromboembolism]. Stiefelhagen P MMW Fortschr Med; 1999 Sep; 141(38):18. PubMed ID: 10904611 [No Abstract] [Full Text] [Related]
5. Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes. ; Mehta SR; Yusuf S; Granger CB; Wallentin L; Peters RJ; Bassand JP; Budaj A; Joyner C; Chrolavicius S; Fox KA Am Heart J; 2005 Dec; 150(6):1107. PubMed ID: 16338245 [TBL] [Abstract][Full Text] [Related]
6. Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library. Petersen JL; Mahaffey KW; Becker RC; Goodman SG; Kleiman NS; Marian AJ; Stone GW; Lansky AJ; Lincoff AM; Hazen SL; Nessel CC; Toro-Figueroa L; Tate L; Reist CJ; Cohen M; Califf RM; Ferguson JJ; Am Heart J; 2004 Aug; 148(2):269-76. PubMed ID: 15308996 [TBL] [Abstract][Full Text] [Related]
7. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin. Santopinto J; Gurfinkel EP; Torres V; Marcos E; Bozovich GE; Mautner B; McCabe CH; Antman EM Am Heart J; 2001 Apr; 141(4):566-72. PubMed ID: 11275921 [TBL] [Abstract][Full Text] [Related]
8. Home treatment of deep venous thrombosis. Force RW J Fam Pract; 1996 Jun; 42(6):566-7. PubMed ID: 8656163 [No Abstract] [Full Text] [Related]
9. [Stroke. Enoxaparin sodium inhibits venous thromboembolism compared to unfractionated heparin]. Drossbach M Med Monatsschr Pharm; 2007 Nov; 30(11):426. PubMed ID: 18062340 [No Abstract] [Full Text] [Related]
10. [A multicenter cooperative study on prevention and treatment of unstable angina associated with acute myocardial infarction and cardiac death]. Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Apr; 21(2):77-9. PubMed ID: 8223166 [No Abstract] [Full Text] [Related]
11. Enoxaparin in acute coronary syndromes. Lee S; Gibson CM Expert Rev Cardiovasc Ther; 2007 May; 5(3):387-99. PubMed ID: 17489664 [TBL] [Abstract][Full Text] [Related]